| Hans-Günter Meyer-Thompson | Hepatitiden
Hepatitis C micro-elimination among people on opioid agonist therapy is a low-hanging fruit.
Hepatitis C micro-elimination among people on opioid agonist therapy is a low-hanging fruit.
Bruggmann P, Maeschli B.
Swiss Med Wkly. 2020 Sep 18;150:w20348. doi: 10.4414/smw.2020.20348. PMID: 33035351.